Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma

被引:187
作者
Takayasu, K
Arii, S
Matsuo, N
Yoshikawa, M
Ryu, M
Takasaki, K
Sato, M
Yamanaka, N
Shimamura, Y
Ohto, M
机构
[1] Natl Canc Ctr Hosp, Dept Diagnost Radiol, Chuo Ku, Tokyo 1140045, Japan
[2] Kyoto Univ, Dept Surg 1, Sakyo Ku, Kyoto 6068507, Japan
[3] Nara Prefectural Med Coll, Dept Radiol, Nara 6348522, Japan
[4] Chiba Sch Med, Dept Med 1, Chuo Ku, Chiba 2608766, Japan
[5] Tokyo Womens Med Coll, Dept Surg, Shinjuku Ku, Tokyo 1628666, Japan
[6] Wakayama Prefectural Med Coll, Dept Radiol, Wakayama 6418509, Japan
[7] Hyogo Sch Med, Dept Surg 1, Nishimiya, Hyogo 6638501, Japan
[8] Chibanishi Hosp, Dept Surg, Kanegasa Ku, Chiba 2702251, Japan
关键词
D O I
10.2214/ajr.175.3.1750699
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. We assessed the role of dynamic CT in the evaluation of the efficacy of transarterial chemoembolization with iodized oil for hepatocellular carcinoma. MATERIALS AND METHODS. We examined 41 hepatocellular carcinoma lesions (mean diameter, 5.0 cm) in 40 patients (mean age, 60.6 years) who underwent transarterial injection of iodized oil alone (n = 3) or emulsion of iodized oil and doxorubicin hydrochloride (n = 10) followed by gelatin sponge particles (n = 27) and subsequent hepatectomy. On dynamic CT performed within 3 weeks before oily transarterial chemoembolization and within 4 weeks before surgery, we calculated the rate of necrosis on the basis of the assumption that the portion that retained iodized oil represented necrosis. We also calculated the reduction rate of the tumor. CT findings were compared with pathologic findings of resected specimens. RESULTS. Pathologic specimens and the necrosis rate measured on CT showed a good correlation (r = 0.83) when the portion of tumor that retained iodized oil was considered necrosis. No correlation existed if the portion that retained iodized oil was considered viable. We noted no significant correlation (r = 0.38) between the reduction rate of the tumor and necrosis rate. Also, we noted no correlation (r = 0.52) between the interval between transarterial oily chemoembolization and surgery and the reduction rate of the tumor. CONCLUSION. CT is suitable for the evaluation of the efficacy of oily chemoembolization for hepatocellular carcinoma on the basis of the assumption that the portion of tumor that retains iodized oil is necrotic. The rate of tumor size reduction measured on CT did not correlate with the therapeutic effect of chemoembolization.
引用
收藏
页码:699 / 704
页数:6
相关论文
共 28 条
[1]   HEPATOCELLULAR-CARCINOMA - CT AND MR FEATURES AFTER TRANSCATHETER ARTERIAL EMBOLIZATION AND PERCUTANEOUS ETHANOL INJECTION [J].
BARTOLOZZI, C ;
LENCIONI, R ;
CARAMELLA, D ;
FALASCHI, F ;
CIONI, R ;
DICOSCIO, G .
RADIOLOGY, 1994, 191 (01) :123-128
[2]   THERAPEUTIC EFFECT OF TRANSCATHETER OILY CHEMOEMBOLIZATION THERAPY FOR ENCAPSULATED NODULAR HEPATOCELLULAR-CARCINOMA - CT AND PATHOLOGICAL FINDINGS [J].
CHOI, BI ;
KIM, HC ;
HAN, JK ;
PARK, JH ;
KIM, YI ;
KIM, ST ;
LEE, HS ;
KIM, CY ;
HAN, MC .
RADIOLOGY, 1992, 182 (03) :709-713
[3]  
Couinaud C., 1957, FOIE ETUDES ANATOMIQ
[4]   PERCUTANEOUS ETHANOL INJECTION FOR THE TREATMENT OF SMALL HEPATOCELLULAR-CARCINOMA - STUDY OF 95 PATIENTS [J].
EBARA, M ;
OHTO, M ;
SUGIURA, N ;
KITA, K ;
YOSHIKAWA, M ;
OKUDA, K ;
KONDO, F ;
KONDO, Y .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1990, 5 (06) :616-626
[5]  
IKEYA S, 1990, JPN J CANC CLIN, V36, P985
[6]   LIPIODOL RETENTION AND MASSIVE NECROSIS AFTER LIPIODOL-CHEMOEMBOLIZATION OF HEPATOCELLULAR-CARCINOMA - CORRELATION BETWEEN COMPUTED-TOMOGRAPHY AND HISTOPATHOLOGY [J].
IMAEDA, T ;
YAMAWAKI, Y ;
SEKI, M ;
GOTO, H ;
IINUMA, G ;
KANEMATSU, M ;
MOCHIZUKI, R ;
DOI, H ;
SAJI, S ;
SHIMOKAWA, K .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 1993, 16 (04) :209-213
[7]   CLINICOPATHOLOGICAL STUDY ON COMBINATION THERAPY CONSISTING OF ARTERIAL INFUSION OF LIPIODOL-DISSOLVED SMANCS AND TRANSCATHETER ARTERIAL EMBOLIZATION FOR HEPATOCELLULAR-CARCINOMA [J].
JINNO, K ;
MORIWAKI, S ;
TANADA, M ;
WADA, T ;
MANDAI, K ;
OKADA, Y .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 :S7-S12
[8]   EFFECT OF ARTERIAL ADMINISTRATION OF HIGH-MOLECULAR-WEIGHT ANTI-CANCER AGENT SMANCS WITH LIPID LYMPHOGRAPHIC AGENT ON HEPATOMA - A PRELIMINARY-REPORT [J].
KONNO, T ;
MAEDA, H ;
IWAI, K ;
TASHIRO, S ;
MAKI, S ;
MORINAGA, T ;
MOCHINAGA, M ;
HIRAOKA, T ;
YOKOYAMA, I .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (08) :1053-&
[9]   HEPATOCELLULAR-CARCINOMA - USE OF COLOR DOPPLER US TO EVALUATE RESPONSE TO TREATMENT WITH PERCUTANEOUS ETHANOL INJECTION [J].
LENCIONI, R ;
CARAMELLA, D ;
BARTOLOZZI, C .
RADIOLOGY, 1995, 194 (01) :113-118
[10]  
LIVRAGHI T, 1992, CANCER, V69, P925, DOI 10.1002/1097-0142(19920215)69:4<925::AID-CNCR2820690415>3.0.CO